Corning’s New Microcarriers Improve Efficiency in Bioprocess Scale-Up

We use cookies to ensure the best experience on our website.
View Cookie Policy
Accept Cookie Policy
Change My Settings
Required for the site to function.
Augment your site experience.
Lets Corning work with partners to enable social features and marketing messages.

Diese Seite wird am besten mithilfe der neuesten Version von Google Chrome oder Mozilla Firefox angezeigt.

Image Alt Text

Corning’s New Microcarriers Improve Efficiency in Bioprocess Scale-Up

Corning’s New Microcarriers Improve Efficiency in

News Releases
Corning’s New Microcarriers Improve Efficiency in Bioprocess Scale-Up
Corning’s New Microcarriers Improve Efficiency in Bioprocess Scale-Up
CORNING, N.Y. | Corning Incorporated | 07. November 2012
Minimize preparation and maximize results for large-scale bioprocess production

Corning Incorporated (NYSE:GLW) today announced a new line of microcarriers for large-scale vaccine and cell therapy manufacturing.

The microcarriers simplify the scale-up of attachment-dependent cells by providing a premeasured, sterile, ready-to-use product for direct transfer into bioreactors. This single-step microcarrier solution replaces several steps traditionally required and allows researchers to minimize lab preparation time and enhance manufacturing results.

“This new offering streamlines large-scale manufacturing, providing researchers with a single-step solution to free up vital resources,” said Ken Ludwig, business manager, Bioprocess and Cell Therapy, Corning Life Sciences. “The new product reflects Corning’s ongoing initiative to provide customers with efficient and complete solutions—from small-scale process development to large-scale manufacturing.”

The new microcarriers offer Corning’s unique Synthemax II and Enhanced Attachment surface treatment options to maximize cell yield and viability, and are fully compatible with closed systems solutions packaging in customizable batch sizes starting at 10g.

The new microcarriers represent the next step in Corning’s ongoing scale-up offerings, joining Corning CellSTACK® culture chambers, Corning HYPERStack® vessels, a full range of spinner flasks, and advanced cell-culture media solutions.

Through acquisition and ongoing R&D investment, Corning now offers a more comprehensive range of innovative laboratory products and solutions for a wide spectrum of life science applications. Corning’s trusted, quality brands, backed by technical expertise, provide researchers with better ways to advance their research from the beginning of their process to the end. The family of brands includes Corning®, PYREX®, Costar®, Axygen®, Gosselin™ and cellgro®.

To learn more about the new Corning Life Sciences microcarriers or any other products, please contact a customer service representative at 1-510-494-8900, or visit .

Forward-Looking and Cautionary Statements

This press release contains “forward-looking statements” (within the meaning of the Private Securities Litigation Reform Act of 1995), which are based on current expectations and assumptions about Corning’s financial results and business operations, that involve substantial risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include: the effect of global political, economic and business conditions; conditions in the financial and credit markets; currency fluctuations; tax rates; product demand and industry capacity; competition; reliance on a concentrated customer base; manufacturing efficiencies; cost reductions; availability of critical components and materials; new product commercialization; pricing fluctuations and changes in the mix of sales between premium and non-premium products; new plant start-up or restructuring costs; possible disruption in commercial activities due to terrorist activity, armed conflict, political or financial instability, natural disasters, adverse weather conditions, or major health concerns; adequacy of insurance; equity company activities; acquisition and divestiture activities; the level of excess or obsolete inventory; the rate of technology change; the ability to enforce patents; product and components performance issues; retention of key personnel; stock price fluctuations; and adverse litigation or regulatory developments. These and other risk factors are detailed in Corning’s filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the day that they are made, and Corning undertakes no obligation to update them in light of new information or future events.

About Corning Incorporated

Corning Incorporated ( ) is the world leader in specialty glass and ceramics. Drawing on more than 160 years of materials science and process engineering knowledge, Corning creates and makes keystone components that enable high-technology systems for consumer electronics, mobile emissions control, telecommunications and life sciences. Our products include glass substrates for LCD televisions, computer monitors and laptops; ceramic substrates and filters for mobile emission control systems; optical fiber, cable, hardware & equipment for telecommunications networks; optical biosensors for drug discovery; and other advanced optics and specialty glass solutions for a number of industries including semiconductor, aerospace, defense, astronomy, and metrology.